This marks the fifth leading pharma organization to adopt LifeSphere NavaX, reinforcing the industry’s trust in AI-driven innovation for drug safety and regulatory operations.
Boston, Massachusetts, USA ...
Over 50 executive speakers and more than 200 expected attendees will explore "AI In Action," advancing automation, GenAI, large language models, and real-world data across pharmacovigilance and regulatory operations
These practices are essential For societal benefits including enhanced patient safety.
These practices are essential For societal benefits including enhanced patient safety.
11 net new LifeSphere customers, 57 customer go-lives, and expanded adoption of NavaX
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved